Skip to main content

D. E. Shaw & Co., Inc.

Position in DSGN — Design Therapeutics, Inc.

CIK 1009207 New York, NY

Position in DSGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$5,003,671
+$886,846 QoQ
Shares Held
470,270
+7.1% QoQ
Ownership
0.753%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $4,382,181,502 across 180 Biotechnology names. DSGN ranks #93 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DSGN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,003,671 470,270
2025-12-31 $4,116,825 438,894
2025-09-30 $2,810,767 373,276
2025-06-30 $1,316,483 390,648
2025-03-31 $1,525,667 395,251
2024-12-31 $3,161,075 512,330
2024-09-30 $3,135,775 582,858
2024-06-30 $1,794,876 535,784
2024-03-31 $1,798,145 446,190
2023-12-31 $770,164 290,628
2023-09-30 $27,706 11,740
2023-06-30 $852,264 135,280
2023-03-31 $642,189 111,298